24-hydroxycholesterol has been researched along with Parkinson Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrescia, P; De Mase, A; Di Natale, C; Monaco, A; Netti, PA; Pedone, C; Tedeschi, G; Tessitore, A | 1 |
Chen, H; Du, G; Hohl, RJ; Huang, X; Kong, L; Lewis, MM; Mailman, RB; Neighbors, J; Sterling, NW; Stetter, C; Sun, D; Zhu, Y | 1 |
Björkhem, I; Brodin, L; Leoni, V; Lövgren-Sandblom, A; Meaney, S; Pålhagen, S; Salveson, L; Svenningsson, P; Winge, K | 1 |
Liu, Q; Zhang, J | 1 |
Blom, HJ; Bosma, H; Bosmans, E; De Bruijn, C; de Vente, J; Delanghe, J; Lütjohann, D; Maes, M; Rieckmann, P; Steinbusch, HW; Teunissen, CE; van Boxtel, MP; Verbeek, MM; Verhey, F; von Bergmann, K; Vreeling, F; Wauters, A | 1 |
1 review(s) available for 24-hydroxycholesterol and Parkinson Disease
Article | Year |
---|---|
Cholesterol metabolism and homeostasis in the brain.
Topics: Alzheimer Disease; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Cholesterol; Gene Expression Regulation; Homeostasis; Humans; Huntington Disease; Hydroxycholesterols; Lipid Metabolism; Neurons; Parkinson Disease; Receptors, Lipoprotein | 2015 |
1 trial(s) available for 24-hydroxycholesterol and Parkinson Disease
Article | Year |
---|---|
Combination of serum markers related to several mechanisms in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; alpha 1-Antichymotrypsin; Alzheimer Disease; Analysis of Variance; Biomarkers; Chi-Square Distribution; Cholesterol; Cysteine; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Interleukin-6; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Reference Values; Serum; Sterols | 2003 |
3 other study(ies) available for 24-hydroxycholesterol and Parkinson Disease
Article | Year |
---|---|
The level of 24-hydroxycholesteryl esters decreases in plasma of patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Esters; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Parkinson Disease | 2018 |
Brain cholesterol metabolism and Parkinson's disease.
Topics: Aged; Brain; Cholesterol; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Parkinson Disease | 2019 |
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Topics: Aged; Case-Control Studies; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Parkinson Disease; Time Factors | 2013 |